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EXPERIEN CE IN B R A ZIL WITH THE USE OF A V A ILA B LE  
SHISTOSOMICIDES IN MASS TREATM ENT CAMPAIGNS
Aluizio Prata*
INTRO DUCTION
Mass treatment for schistosomiasis ideally 
refers to the universal treatment of whole 
populations living in endemic areas, however as 
non toxic drugs are not yet available for 
schistosomiasis, treatment should not apply to 
ali members of such communities as with 
malaria. Vianna Martins15 defines it as being a 
simultaneous or almost simultaneous treatment 
of a.large number of people representative of a 
population. Although the lack of single dose 
therapy in the past made it difficult to establish 
mass treatment for schistosomiasis, programmes 
have been carried out which could be consider- 
ed as mass treatments, reaching large members 
of people infected by Schistosoma in a well 
defined population.
Programes of Mass Treatment in Brazil
Antimony compounds. Heraldo Maciel14 first 
used antimony compounds in Brazil for mass 
treatment of schistosomiasis. He treated 1.063 
sailors (9% of the Brazilian Navy) in the period 
of 1923 — 1928. Tartar emetic was used in a 
total dose of 0.95 g intravenously administered 
over a period of ten days. He claimed 92% 
success in therapy.
In 1943, treatment of schistosomiasis beca- 
me compulsory in the village of Catende in the 
state of Pernambuco10. Seven thousand people 
were examined and 4,171 were found to have 
Schistosoma eggs in their stools. In the period 
of 1943 to 1947, 3,539 people started treat­
ment of which 3,334 completed it. The drug 
used was tartar emetic. Only one death was 
reported. Although this form of treatment was 
not widely accepted in the period of 1949 to 
1952, 582 more people were treated. The 
efficacy of this therapy was assessed by stool 
examinations in the three months following 
therapy, and sixty four per cent of treated 
patients were found to have negative stools.
From 1951 onwards, Sette18 set up a long 
term follow-up to assess treatment of schistoso­
miasis in Catende. He reviewed 1,094 treated 
patients and compared them with a similar 
group of non treated patients; he found that 
40% of the treated group still passed eggs in 
stools as compared to 66% in the control group. 
Liver function tests were better in the treated 
group, and only 1.7% of patients progressed to 
the hepatosplenic form as compared to 9% in 
the non treated group. Since histopathological 
examinations had been carried out as a routine 
in those who died in the area before and after 
introdution of compulsory therapy for schisto-
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somiasis, it was possible to analyse the prevalen- 
ce of schistosomotic lesions in the population, 
It was found that such lesions were prevalent in 
the order of 16.5% before treatment and 11.5% 
after treatment. As far as hepatic fibrosis is 
concerned, its prevalence was 5.4% before 
treatment and 1.3% after treatment Althought 
his data are very important, his control groups 
were too small (sometimes only 25 cases) to 
enable us to draw any definite conclusions. It is 
noteworthy that in the village of Catende, 
together with the compulsory treatment for 
schistosomiasis, a hygiene education campaign 
was set up and moluscicides were introduced, 
although these measures were not continued18.
After the discovery of an endemic area in 
the town of Araxá, State of Minas Gerais, ali 
those passing Schistosoma eggs in stools were 
treated using neo-antimosan. A  year later, 
Rodrigues da Silva19 showed that 85% of 
treated patients were still passing eggs in their 
stools. Such a high prevalence of positive stool 
examinations could well be explained however 
by either re-infection or failure in therapy. The 
same high prevalence of positive stool examina­
tions after treatment was found in the village of 
Redenção, in the state of Ceará. Rodrigues da 
Silva commenting on this says that re-infection 
may well explain the high prevalence of positive 
stool examinations in patients treated in Reden­
ção, whereas in Araxá failure in therapy could 
well be the case2 1. Neo-antimosan however was 
succesfully used in Fordlandia, in the state of 
Pará. One hundred and thirty patients out of a 
population of 2.000 were treated in the period 
of 1954 to 1956 and in 1962 only 19 patients 
were found to pass schistosoma eggs in their 
stools. These were treated9, and now Fordlan­
dia is no longer an endemic area.
By 1956, 15,000 patients in the Northeast 
of Brazil had been treated by the Ministry of 
Health through a national campaign20;
10,000 more were treated in 195722. The drugs 
used were: 1) Neo-antimosan in a total dose of 
1 ml (8.5 mg Sb+++) per kg. b.w. intramuscular- 
ly over a period of 12 days; 2) Antimony 
dimercaptosuccinate in a dose of 40 mg/kg.b.w. 
íntramuscularly over six days; 3) Sodium anti­
mony I gluconate in a dose of 17 mg/kg.b.w. 
intravenously over six days. About 80% of 
patients completed treatment and only one 
death was reported20. The cure rate was 
assessed by four stool examinations in the four 
months following treatment and was found to 
be 70%16. This treament was carried out by 
local clinics, one of them (Itaporanga) had
6,000 patients. Rodrigues da Silva22 analysing 
the results of this campaign stressed that the 
elderly group of treated patients presented 
higher rates of negative stools. In Itaporanga 
the rate of positive stool examinations dropped 
from 78.5% to 59.5%.
In the period 1962 to 1971, 82,276 more 
patients were treated by the Ministry of Health; 
this figure does not ínclude patients treated by 
health services in different States of the coun- 
try9. The results however of this campaign have 
not yet been analised.
Freitas9 criticized governmental programmes 
for the control and treatment of schistosomiasis 
in Brazil — mass treatment included-chiefly 
because of lack of continuity.
Kloetzel13 treated 112 youngsters with an 
antimonial drug in the village of Gameleira, in 
the State of Pernambuco. Gameleira has 5,000 
inhabitants and is located in an endemic area. A 
90% decrease in stool egg excretion was found 
after one year of treatment.
Following Davis' concept of mass chemothe- 
rapy specifc to an age group. Prata et ai1, from 
1952 to 1973 treated 1,679 navy trainees in the 
state of Bahia. Ali those who joined the Navy 
during that time were investigated by stool 
examination and rectal biopsy, and those who 
were found to be positive were allocated to 
different schemes of teatment. More than 20 
schedules were used and the cure rate was 
largely dependant on the kind of scheme used.
Hycanthone — The great advantage of hycan- 
thone therapy has been the possibility of a 
single dose therapy, making it suitable for mass 
treatment8.
Piza17, in the State of São Paulo, has the 
largest series of treated patients with hycan­
thone, and so far 61,461 patients have been 
treated. The initial schedule recommended by 
the campaign against schistosomiasis in this 
state was 3 mg/kg.b.w. but later reduced to 
2.5 mg/kg. b.w. Although this campaign is still 
in progress, its results have not yet been 
assessed. A  complicating factor is that internai 
immigration is responsible for the ever increa- 
sing extent of endemic area in the state of São 
Paulo. According to the selection and guidance 
immigrant service, at least 36,000 new schisto­
somiasis patients moved to São Paulo in the 
period of 1973-1974.
In the period of 1973-1975, 25,798 patients 
were treated with hycanthone by the Ministry 
of Health. Seventy five per cent of these 
patients were from the States of Paraiba, 
Espírito Santo, Rio de Janeiro and Paraná.
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There are however no available data on the 
results of this treatment.
Bina and Prata3 treated 211 schistosomatic 
patients living in Varzea Nova, an area where 
transmission of the disease was low. The age 
range was 2-74 years and 15 patients had the 
hepatosplenic form of the disease, while 196 
had the hepato-intestinal form. Hycanthone 
was used in a single dose of 2.5 mg/kg. b.w. 
intramuscularly. Only pregnant women and two 
other patients with contraindications were not 
treated. Side effects were nausea, vomiting, 
anorexia, dizziness, headache, drowsiness, sleep- 
ness and pain at the site of the injection. 
Howeyer they were only mild or moderate and 
not lasting more than 24 hours. In only 4 
patients were positive stools found in five 
examinations after five months of treatment, 
and in only one after 16 months.
Hycanthone, in a single intramuscular dose 
of 3.3 mg/kg of body weight, was used to treat 
597 persons in the endemic village of Canabrava 
in the state of Bahia4. Eighty three per cent of 
the total population was treated, leaving only 
7% of patients with Schistosomiasis not treated. 
Treatment was given to the whole group over 
two days, the drug being well tolerated with the 
frequency and intensity of toxic reactions and 
side effects similar to those observed in Varzea 
Nova. After five stool examinations 14 months 
later, 152 patients (25.5%) were still passing 
eggs in stools. Ninety two positive patients were 
then re-treated with hycanthone using the same 
schedule. There was one death probably caused 
by toxic hepatitis. The first stool examination 
after the second treatment was negative in 77% 
of the patients, in comparison with the 93,7% 
after the first one. This suggests the possibility 
of acquired resistance. The final stool examina­
tion 38 months after the initial treatment, 
showed 19% of patients passing eggs, This 
percentage is considerably better than the 
pre-treatment value of 46.3%, and applies for 
ali ages (see graph).
Similar results were obtained by Aguirre et 
at in the states of Rio de Janeiro and Rio 
Grande do Norte1.
Katz et a ll 1 treated 760 patients in the 
village of Baldim in the state of Minas Gerais. 
Only 16 pregnant women and another 22 
patients with serious concurring disease were 
not treated. Hycanthone was used in a single 
dose of 2.5 mg/kg b.w. intramuscularly. Side 
effects were nausea, vomiting, anorexia, muscle 
pain, headache, dizziness, and tenderness at the 
site of injection, but they were mild to modera­
te and disappeared in 24 hours. The percentage 
cure after three negative stool examinations was 
95.6%. Katz stressed the fact that he had 
already treated more than 9,000 patients with- 
out fatality or even jaundice.
Therefore in the past five years more than
100,000 people have been treated as part of 
controlled therapeutic programmes, and the 
manufacturers of hycanthone claimed that by 
June 1975, 433,018 patients had been treated 
ín Brazil.
Oxamniquine — Bina and Prata5 treated 75 
children aged from 3 to 12 years in Taquarendi 
in the State of Bahia. This is an endemic area 
but where transmission has been prevented.
An oral suspension of oxamniquine was 
used in single dose of 15-25 mg/kg b.w. 
Twenty one per cent of the patients had one or 
more of the following side effects: dizziness, 
drowsiness, nausea and occasionally vomiting, 
but they disappeared spontaneously in one to 
two hours. The cure rate was 88%. Another 
group of 313 patients with the hepato-splenic 
form of schistosomiasis was treated by the same 
authors in Mirangaba. (Bahia), where there is 
also no transmission of schistosomiasis. Oxam­
niquine was used in capsule form for adults in a 
dose 12,5 — 15 mg/kg b.w., and in suspension 
form for children in a dose of 20 mg/kg b.w. 
Fifty six per cent of patients had one or more 
of the following symptoms: dizziness, drowsi­
ness, headache, nausea (7.34%), vomiting 
(2.85%). These side effects disappeared in the 
following two hours after treatment. The cure 
rate was assessed by five stool examinations in 
the six months following treatment, and 84% of 
patients were found to have negative stool 
examinations.
The same authors treated 286 patients in the 
endemic area of Boa Esperança in the state of 
Bahia. The number of patients treated represen- 
ted 87.7% of the whole population and 11.4% 
of them had a severe form of the disease. 
Oxamniquine dose was the same and side 
effects were similar to previously reported in 
Mirangaba.
Coura et at6 treated 504 patients in two 
different viliages in the Rio Doce basin in the 
State of Minas Gerais. They were 310 patients 
in São Geraldo, comprising the whole popula­
tion, and 194 patients in Itanhomi (25%ofthe 
population). Oxamniquine was used in a singgle 
dose of 12.5 - 18 mg/kg b.w. Side effects were 
dizziness (13.6%), nausea (2.3%), headache 
(2.3%), vomiting (1.6%), abdominal pain 
(0.9%). Two patients had pshychiatric distur-
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bances: one became aggressive and the other 
presented perceptual disturbances. Apart from 
these two patients, side effects were mild and 
transient not requiring medication. Evaluation 
is still in progress, but so far 87.2% of patients 
show negative stools.
Katz and Zicker12, using a single oral dose 
of oxamniquine of 20 mg/kg b.w. for children 
and 15 mg/b.w. for adults, treated 220 patients 
in the village of Peri Peri in the state of Minas 
Gerais. Side effects were mild and the authors 
recommend the drug for the treatment of 
communities. The cure rates assessed by 2-4 
stools examinations four months after therapy 
were found to be 65,5% for children and 82.4% 
for adults.
The manufacturers stated that by June 1975 
oxamniquine had been given to more than
100,000 patients without fatality or even 
jaundice.
In conclusion, apart from the two cases of 
neuropshychiatric disturbances reported by 
Coura et al, no serious complication has been 
observed with oxamniquine.
COMMENTS
Mass treatment of schistosomiasis in the past 
was done cautiously with antimony compounds 
and large numbers of patients were treated by 
the Ministry of Health through health clinics. 
Toxicity of antimony cmpounds, long term 
therapy, difficulty in injecting the drug and the 
possibility of re-infection hindered the pilot 
projects. Furthermore patients co-operated 
poorly and the mass treatment in the village of 
Catende left doubts as to the applicability of 
this kind of treatment in Brazil.
This situation was not altered by the use of 
Niridazole once it was found that large numbers 
of patients-particularly those with hepatosple-
nomegaly-complained of various neurological 
symptons.
During the last six years however, the 
introduction of single dose therapy has made 
easier mass treatment of schistosomiasis. Hy- 
canthone has been used in various pilot projects 
and at presente two very large compaigns are 
still in progress. Unfortunately with the treat­
ment of more cases reports of severe toxic 
hepatitis have appeared2 and the possibility of 
resistance after the first dose, together with 
accusations of teratogenic, carcinogenic and 
mutagenic effects -  although not substan- 
tiated24, — have reduced the use of hycanthone 
as a drug for mass treatment. However it has 
been used in this way in Brazil with more than
100,000 patients.
Oxamniquine in oral form raised optimism 
as a suitable drug for mass treatment of 
schistosomiasis, but so far it has only been used 
in pilot projects.
Perhaps we are not far away from introdu- 
cing mass treatment for schistosomiasis as for 
malaria. This is not possible with hycanthone 
and as yet we do not know whether it will be 
possible with oxamniquine; we may have to 
await the emergence of a new drug.
It is evident that mass treatment of schisto­
somiasis is the best form of treatment in a non 
endemic area, as was seen in Fordlandia where 
the disease was eradicated by specific treat­
ment, and in Varzea Nova where it was contro- 
led.
The Brazilian experience shows that during 
the long term, treatment may decrease the 
prevalence of the disease even in endemic areas 
-  although it is difficult to assess it in terms of 
the general control of the disease.
It appears that treatment of schistosomiasis 
prevents the appearance of serious forms of the 
disease.
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